Testing effectiveness (Phase 2)Study completedNCT00512317What this trial is testingOpen-label Extension to Protocol 1042-0600Who this might be right forEpilepsies, Partial Marinus Pharmaceuticals 123
Testing effectiveness (Phase 2)Study completedNCT00465517What this trial is testingA Randomized, Controlled Trial of Ganaxolone in Adult Uncontrolled Partial-Onset SeizuresWho this might be right forPartial EpilepsyCatamenial Epilepsy Marinus Pharmaceuticals 147
Testing effectiveness (Phase 2)Study completedNCT00849212What this trial is testingAn add-on Study of E2007 in Patients With Refractory Partial Seizures Uncontrolled With Other Anti-epileptic Drugs (AEDs)Who this might be right forRefractory Partial Seizures Eisai Co., Ltd. 30
Not applicableStudy completedNCT00771927What this trial is testingPost-Authorization Safety Study to Assess the Safety of Vimpat as add-on Therapy in Patients With Partial-onset SeizuresWho this might be right forEpilepsies, Partial UCB Pharma 1,005
Not applicableActive Not RecruitingNCT05859854What this trial is testingCenobamate in Adults With Focal-Onset SeizuresWho this might be right forEpilepsyFocal-Onset SeizureNeurological Disorder Aziende Chimiche Riunite Angelini Francesco S.p.A 936
Not applicableLooking for participantsNCT06922175What this trial is testingREACH: RWE Retrospective Study to Evaluate Cenobamate Impact on Health Care Resource UtilizationWho this might be right forEpilepsy With Uncontrolled Focal-onset Seizures Aziende Chimiche Riunite Angelini Francesco S.p.A 200
Testing effectiveness (Phase 2)Study completedNCT00903786What this trial is testingA Long-term Extension Study of E2007 in Patients With Refractory Partial Seizures Uncontrolled With Other Anti-Epileptic Drugs (AEDs)Who this might be right forRefractory Partial Seizures Eisai Co., Ltd. 21